Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells

Experimental Cell Research

Volumn 333, Issue 1, 2015, Pages 39-48

  Chavkin, Nicholas W ^a   Chia, Jia Jun ^a   Crouthamel, Matthew H ^a   Giachelli, Cecilia M ^a  

^a University of Washington   (United States)

Author keywords

Calcification; ERK phosphorylation; Phosphate; PiT 1; Signaling; SLC20A1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR PIT 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATE; SODIUM PHOSPHATE COTRANSPORTER 3;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHATE TRANSPORT; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD VESSEL CALCIFICATION; C57BL MOUSE; CELL CULTURE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; TRANSGENIC MOUSE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHATES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; VASCULAR CALCIFICATION;

EID: 84926409751     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.02.002     Document Type: Article

References (34)

1. Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., Liu K., Shea S., Szklo M., Bluemke D.A., O'Leary D.H., Tracy R., Watson K., Wong N.D., Kronmal R.A. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 2008, 358:1336-1345.
2. Shroff R.C., McNair R., Figg N., Skepper J.N., Schurgers L., Gupta A., Hiorns M., Donald A.E., Deanfield J., Rees L., Shanahan C.M. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008, 118:1748-1757.
3. Nakamura S., Ishibashi-Ueda H., Niizuma S., Yoshihara F., Horio T., Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin. J. Am. Soc. Nephrol. 2009, 4:1892-1900.
4. Tonelli M., Wiebe N., Culleton B., House A., Rabbat C., Fok M., McAlister F., Garg A.X. Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 2006, 17:2034-2047.
5. Block G.A., Hulbert-Shearon T.E., Levin N.W., Port F.K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am. J. Kidney Dis. 1998, 31:607-617.
6. Young E.W., Albert J.M., Satayathum S., Goodkin D.A., Pisoni R.L., Akiba T., Akizawa T., Kurokawa K., Bommer J., Piera L., Port F.K. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005, 67:1179-1187.
7. Adeney K.L., Siscovick D.S., Ix J.H., Seliger S.L., Shlipak M.G., Jenny N.S., Kestenbaum B.R. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J. Am. Soc. Nephrol. 2009, 20:381-387.
8. Hruska K.A., Mathew S., Lund R., Qiu P., Pratt R. Hyperphosphatemia of chronic kidney disease. Kidney Int. 2008, 74:148-157.
9. Kestenbaum B. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment. Semin. Dial. 2007, 20:286-294.
10. Levin A., Bakris G.L., Molitch M., Smulders M., Tian J., Williams L.A., Andress D.L. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007, 71:31-38.
11. Isakova T., Wahl P., Vargas G.S., Gutiérrez O.M., Scialla J., Xie H., Appleby D., Nessel L., Bellovich K., Chen J., Hamm L., Gadegbeku C., Horwitz E., Townsend R.R., Anderson C.A., Lash J.P., Hsu C.Y., Leonard M.B., Wolf M. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011, 79:1370-1378.
12. Shanahan C.M., Crouthamel M.H., Kapustin A., Giachelli C.M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ. Res. 2011, 109:697-711.
13. Li X., Yang H.Y., Giachelli C.M. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ. Res. 2006, 98:905-912.
14. Dai X.Y., Zhao M.M., Cai Y., Guan Q.C., Zhao Y., Guan Y., Kong W., Zhu W.G., Xu M.J., Wang X. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int. 2013, 83:1042-1051.
15. Crouthamel M.H., Lau W.L., Leaf E.M., Chavkin N.W., Wallingford M.C., Peterson D.F., Li X., Liu Y., Chin M.T., Levi M., Giachelli C.M. Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2. Arterioscler. Thromb. Vasc. Biol. 2013, 33:2625-2632.
16. El Husseini D., Boulanger M.C., Fournier D., Mahmut A., Bossé Y., Pibarot P., Mathieu P. High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1. PLoS ONE 2013, 8:e53393.
17. Villa-Bellosta R., Bogaert Y.E., Levi M., Sorribas V. Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1030-1036.
18. Ravera S., Virkki L.V., Murer H., Forster I.C. Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements. Am. J. Physiol. Cell Physiol. 2007, 293:C606-C620.
19. Jono S., McKee M.D., Murry C.E., Shioi A., Nishizawa Y., Mori K., Morii H., Giachelli C.M. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 2000, 87:E10-E17.
20. Speer M.Y., Yang H.Y., Brabb T., Leaf E., Look A., Lin W.L., Frutkin A., Dichek D., Giachelli C.M. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ. Res. 2009, 104:733-741.
21. Bøttger P., Pedersen L. Mapping of the minimal inorganic phosphate transporting unit of human PiT2 suggests a structure universal to PiT-related proteins from all kingdoms of life. BMC Biochem. 2011, 12:21.
22. Beck L., Leroy C., Salaün C., Margall-Ducos G., Desdouets C., Friedlander G. Identification of a novel function of PiT1 critical for cell proliferation and independent of its phosphate transport activity. J. Biol. Chem. 2009, 284:31363-31374.
23. Salaün C., Leroy C., Rousseau A., Boitez V., Beck L., Friedlander G. Identification of a novel transport-independent function of PiT1/SLC20A1 in the regulation of TNF-induced apoptosis. J. Biol. Chem. 2010, 285:34408-34418.
24. Bourgine A., Pilet P., Diouani S., Sourice S., Lesoeur J., Beck-Cormier S., Khoshniat S., Weiss P., Friedlander G., Guicheux J., Beck L. Mice with hypomorphic expression of the sodium-phosphate cotransporter PiT1/Slc20a1 have an unexpected normal bone mineralization. PLoS ONE 2013, 8:e65979.
25. +/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway. Bone 2010, 47:938-947.
26. Yamazaki M., Ozono K., Okada T., Tachikawa K., Kondou H., Ohata Y., Michigami T. Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells. J. Cell. Biochem. 2010, 111:1210-1221.
27. Liu L., Sánchez-Bonilla M., Crouthamel M., Giachelli C., Keel S. Mice lacking the sodium-dependent phosphate import protein, PiT1 (SLC20A1), have a severe defect in terminal erythroid differentiation and early B cell development. Exp. Hematol. 2013, 41(432-43):e7.
28. Beck L., Leroy C., Beck-Cormier S., Forand A., Salaün C., Paris N., Bernier A., Ureña-Torres P., Prié D., Ollero M., Coulombel L., Friedlander G. The phosphate transporter PiT1 (Slc20a1) revealed as a new essential gene for mouse liver development. PLoS ONE 2010, 5:e9148.
29. Meloche S., Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26:3227-3239.
30. Wada T., Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004, 23:2838-2849.
31. Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol. Res. 2012, 66:105-143.
32. Ito M., Haito S., Furumoto M., Uehata Y., Sakurai A., Segawa H., Tatsumi S., Kuwahata M., Miyamoto K. Unique uptake and efflux systems of inorganic phosphate in osteoclast-like cells. Am. J. Physiol. Cell Physiol. 2007, 292:C526-C534.
33. Reynolds J.L., Joannides A.J., Skepper J.N., McNair R., Schurgers L.J., Proudfoot D., Jahnen-Dechent W., Weissberg P.L., Shanahan C.M. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J. Am. Soc. Nephrol. 2004, 15:2857-2867.
34. Kapustin A.N., Davies J.D., Reynolds J.L., McNair R., Jones G.T., Sidibe A., Schurgers L.J., Skepper J.N., Proudfoot D., Mayr M., Shanahan C.M. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ. Res. 2011, 109:e1-e12.